Making (Anti)Sense of factor XI in thrombosis

New England Journal of Medicine

Volumn 372, Issue 3, 2015, Pages 277-278

  Flaumenhaft, Robert ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BLOOD CLOTTING FACTOR 11; ENOXAPARIN; FACTOR 11 ANTISENSE OLIGONUCLEOTIDE; UNCLASSIFIED DRUG; ANTICOAGULANT AGENT; ISIS 416858; OLIGONUCLEOTIDE;

BLEEDING; BLEEDING TIME; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; HUMAN; INCIDENCE; KNEE ARTHROPLASTY; NONHUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); PHLEBOGRAPHY; RISK; THROMBOSIS; THROMBOSIS PREVENTION; ANTAGONISTS AND INHIBITORS; FEMALE; MALE; POSTOPERATIVE COMPLICATIONS; VENOUS THROMBOSIS;

ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT, KNEE; FACTOR XI; FEMALE; HUMANS; MALE; OLIGONUCLEOTIDES; OLIGONUCLEOTIDES, ANTISENSE; POSTOPERATIVE COMPLICATIONS; VENOUS THROMBOSIS;

EID: 84920973015     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1413874     Document Type: Editorial

References (7)

1. Wang X, Cheng Q, Xu L, et al. Effects of factor IX or factor XI deficiency on ferric chloride-induced carotid artery occlusion in mice. J Thromb Haemost 2005;3:695-702.
2. Tucker EI, Marzec UM, White TC, et al. Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI. Blood 2009;113:936-44.
3. Crosby JR, Marzec U, Revenko AS, et al. Antithrombotic effect of antisense factor XI oligonucleotide treatment in primates. Arterioscler Thromb Vasc Biol 2013;33:1670-8.
4. Yau JW, Liao P, Fredenburgh JC, et al. Selective depletion of factor XI or factor XII with antisense oligonucleotides attenuates catheter thrombosis in rabbits. Blood 2014;123:2102-7.
5. Büller HR, Bethune C, Bhanot S, et al. Factor XI antisense oligonucleotide for prevention of venous thrombosis. N Engl J Med 2015;372:232-40.
6. Lassen MR, Ageno W, Borris LC, et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. N Engl J Med 2008;358:2776-86.
7. Lassen MR, Raskob GE, Gallus A, Pineo G, Chen D, Hornick P. Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial. Lancet 2010;375:807-15.